PRJNA381632
Clonal Evolution underlying leukemia progression and Richter transformation in ibrutinib-relapsed CLL patients
Serial samples from CLL patients who relapsed post treatment with BTK-inhibitor, Ibrutinib (Ibr), sequenced using UCM-OncoPlus (a 1200 hybrid capture gene panel from University of Chicago)